Results 101 to 110 of about 17,905 (230)

A Cross‐Sectional Study to Determine Candida spp. Carriage in Libyan Patients With Type 2 Diabetes

open access: yesBioMed Research International, Volume 2026, Issue 1, 2026.
The risk for Candida infections in patients with diabetes mellitus (DM) is three times higher than in the general population. Despite a DM prevalence of 15.8% reported in Libya (2024), the laboratory identification and susceptibility testing of fungal infections in patients with DM are not routinely performed.
Mustafa H. M. Esmaio   +3 more
wiley   +1 more source

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants

open access: yesJournal of Health Economics and Outcomes Research, 2015
# Objectives Compare the cost of the primary prophylaxis of invasive fungal infections (IFI) with voriconazole, posaconazole, and micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) in hospitals of the National ...
Santiago Grau   +8 more
doaj   +1 more source

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America [PDF]

open access: yes, 2017
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America.
Andes, David   +13 more
core  

The seizure of illicit assets: patterns of civil forfeiture in Canada and Ireland [PDF]

open access: yes, 2013
No description ...
Gallant, M Michelle, King, Colin
core   +1 more source

Autopsy Findings in a Case of Lomentospora prolificans Fungemia in Myelodysplastic Syndrome

open access: yesCase Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
Background Lomentospora prolificans is a soil‐, plant‐, or animal‐borne mold that can affect immunocompromised hosts. Most L. prolificans infections are identifiable in the bloodstream. L. prolificans fungemia has never been reported in an autopsy. Case Report We treated a 79‐year‐old man with myelodysplastic syndrome (MDS), MDS‐EB‐1 subtype.
Osamu Imataki   +5 more
wiley   +1 more source

Pharmacokinetics of micafungin in patients treated with extracorporeal membrane oxygenation: an observational prospective study

open access: yesRevista Brasileira de Terapia Intensiva, 2020
Objective To determine micafungin plasma levels and pharmacokinetic behavior in patients treated with extracorporeal membrane oxygenation. Methods The samples were taken through an access point before and after the membrane in two tertiary hospitals in ...
M. López‐Sánchez   +5 more
semanticscholar   +1 more source

Lethal Case of Bourbon Virus Leading to Shock and ECMO Utilization

open access: yesCase Reports in Infectious Diseases, Volume 2026, Issue 1, 2026.
We present a lethal case of Bourbon virus infection in a 63‐year‐old Caucasian, diabetic male who was previously in good health. The patient had spent time in the wooded areas of Bourbon County, Kansas, and removed three ticks from his body 5 days prior to presentation.
Allianna Mitchell   +7 more
wiley   +1 more source

Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database

open access: yesThrombosis Journal
Background Echinocandins belong to the fourth generation of antifungals, and there are no systematic studies on their risk in coagulation dysfunction; this study will predict the risk of coagulation dysfunction of echinocandins using the US Food and Drug
Qian Cheng   +7 more
doaj   +1 more source

Case Report: Micafungin for treating Candida glabrata urinary infection: a clinical case in a premature neonate

open access: yesFrontiers in Pediatrics
Urinary tract infections (UTIs) associated with indwelling urinary catheterization (IUC) in premature newborns (PNBs) pose a significant challenge in neonatal intensive care units (NICUs) due to the vulnerability of this population to infections and the ...
Carlos Javier Parramon-Teixido   +6 more
doaj   +1 more source

The activity of micafungin against clinical isolates of non-albicans Candida spp.

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2015
Infections caused by non-albicans Candida spp. are an important medical problem in people from risk groups, e.g. hematooncological patients. The aim of this paper was to analyse the in vitro activity of micafungin against 30 clinical isolates of non ...
Biernasiuk Anna   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy